Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.


Pharma Blocks Democrats’ Drug Pricing Plan

Democrats failed to gain sufficient support to advance long-debated legislation to permit Medicare drug price negotiations.

Biden Bolsters Vaccine Production in Pandemic Preparedness Plan

The White House announced a nearly $3 billion program to ramp up production of vaccines and their components.

Biosimilars Move to Center Stage

Will FDA’s approval of Semglee create a surge in the development of interchangeable biosimilars?

FDA and Industry Map New R&D Initiatives under Next User Fee Program

FDA formally unveiled its plan for revising and renewing its fee program for drugs and biologics.